Genmab A (GMAB) Common Equity (2023 - 2026)
Genmab A (GMAB) reported Common Equity of $5.96 billion for the quarter ended Jun 30, 2026, up 4.8% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Common Equity (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A posted Common Equity of $5.85 billion, up 13.8% from the prior year.
- Common Equity has increased for seven consecutive years, with a five-year compound annual growth rate of 21.4% (years ended Dec 2020 to Dec 2025).
- By year, Common Equity came in at $5.14 billion in the year ended Dec 31, 2024 (+9.6%), $4.69 billion in the year ended Dec 31, 2023 (+84.1%), $2.55 billion in the year ended Dec 31, 2022 (+1.5%) and $2.51 billion in the year ended Dec 31, 2021 (+12.9%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Common Equity in data going back to the quarter ended Dec 31, 2018.
- The high point for year-over-year Common Equity in five years was the quarter ended Sep 30, 2021 (growth of 766.5%); the low point was the quarter ended Dec 31, 2023 (a decline of 24.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.72 Bn | 1,135.31 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 647.94 Bn | 567.80 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 504.05 Bn | 477.16 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.05 Bn | 322.43 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 303.17 Bn | 267.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 269.10 Bn | 242.78 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 242.44 Bn | 197.84 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 195.21 Bn | 169.41 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Genmab A | 2.58 Bn | -2.80 Bn | 1.07 Bn | 5.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96 Bn |
| Mar 31, 2026 | 5.68 Bn |
| Dec 31, 2025 | 5.85 Bn |
| Sep 30, 2025 | 774.93 Mn |
| Jun 30, 2025 | 5.30 Bn |
| Mar 31, 2025 | 5.30 Bn |
| Jun 30, 2024 | 4.45 Bn |
| Jan 1, 2023 | 3.92 Bn |
API Access
Genmab A Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();